Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Risk Factors and Incidence of Macular Edema after Cataract Surgery
2015276 citationsColin J. Chu, Robert L. Johnston et al.profile →
Defining response to anti-VEGF therapies in neovascular AMD
2015262 citationsWinfried M. K. Amoaku, Usha Chakravarthy et al.Eyeprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Yit C. Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yit C. Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yit C. Yang more than expected).
This network shows the impact of papers produced by Yit C. Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yit C. Yang. The network helps show where Yit C. Yang may publish in the future.
Co-authorship network of co-authors of Yit C. Yang
This figure shows the co-authorship network connecting the top 25 collaborators of Yit C. Yang.
A scholar is included among the top collaborators of Yit C. Yang based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Yit C. Yang. Yit C. Yang is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Narendran, Nirodhini & Yit C. Yang. (2020). The efficacy and safety of brolucizumab compared with aflibercept in polypoidal choroidal vasculopathy: 24-month results from the HAWK study..1 indexed citations
Chu, Colin J., Andrew D. Dick, Robert L. Johnston, Yit C. Yang, & Alastair K. Denniston. (2017). Cataract surgery in uveitis: a multicentre database study. British Journal of Ophthalmology. 101(8). 1132–1137.37 indexed citations
10.
Fitzpatrick, Martin, et al.. (2015). Metabolomic analysis of urine in patients with age related macular degeneration. Investigative Ophthalmology & Visual Science. 56(7). 368–368.1 indexed citations
11.
Amoaku, Winfried M. K., Usha Chakravarthy, Richard Gale, et al.. (2015). Defining response to anti-VEGF therapies in neovascular AMD. Eye. 29(6). 721–731.262 indexed citations breakdown →
12.
Paraoan, Luminita, et al.. (2014). AGE-related Modulation of Cystatin C Expression, Secretion and Polarity in the Retinal Pigment Epithelium. Investigative Ophthalmology & Visual Science. 55(13). 1331–1331.
13.
Butler, Joe M., et al.. (2014). Cysteine proteases expression and secretion by retinal pigmented epithelium (RPE). Investigative Ophthalmology & Visual Science. 55(13). 410–410.1 indexed citations
Comyn, Oliver, Sobha Sivaprasad, Philip Hykin, et al.. (2013). Differences in the topographic profile of retinal thickening in cases of diabetic macular edema with and without serous macular detachment. Investigative Ophthalmology & Visual Science. 54(15). 4928–4928.1 indexed citations
16.
Fitzpatrick, Martin, et al.. (2013). Metabolomic analysis in patients with age related macular degeneration. Investigative Ophthalmology & Visual Science. 54(15). 3662–3662.3 indexed citations
17.
Gibson, Jane Whitney, Helen Griffiths, Gabriella De Salvo, et al.. (2012). Genome-wide association study of primary open angle glaucoma risk and quantitative traits.. PubMed. 18. 1083–92.33 indexed citations
18.
Conway, Miriam L., et al.. (2012). Investigating Eye Clinic Liaison Officers (ECLOs) using quality of life questionnaires. Investigative Ophthalmology & Visual Science. 53(14). 4406–4406.2 indexed citations
19.
Yang, Yit C.. (2007). Two Year Contrast Sensitivity Results From the Anchor Study Comparing Intravitreal Ranibizumab 0.3mg and 0.5mg With Verteporfin PDT for Predominantly Classic CNV Lesions Secondary to Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 48(13). 4545–4545.4 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.